Cargando…
Design, Synthesis and Phenotypic Profiling of Simplified Gedatolisib Analogues
Targeted antitumour therapy has revolutionized the treatment of several types of tumours. Among the validated targets, phosphatidylinositol-3 kinase (PI3K) deserves to be highlighted. Several PI3K inhibitors have been developed for the treatment of cancer, including gedatolisib (4). This inhibitor w...
Autores principales: | Costa, Caroline Marques Xavier, Aparecida-Silva, Cristiane, Gamba, Luis Eduardo Reina, de Melo, Thalita Neves, Barbosa, Gisele, de Moraes Junior, Manoel Oliveira, de Oliveira, Victoria Regina Thomaz, de Amorim, Carolinne Souza, Moraes, João A., Barreiro, Eliezer Jesus, Lima, Lídia Moreira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964390/ https://www.ncbi.nlm.nih.gov/pubmed/37259357 http://dx.doi.org/10.3390/ph16020209 |
Ejemplares similares
-
Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells
por: Murase, Yusuke, et al.
Publicado: (2022) -
Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer
por: Wilson, George D., et al.
Publicado: (2020) -
Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity
por: de Queiroz, Aline Cavalcanti, et al.
Publicado: (2022) -
Design, Synthesis, Antinociceptive and Anti-Inflammatory Activities of Novel Piroxicam Analogues
por: de Miranda, Amanda Silva, et al.
Publicado: (2012) -
Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs
por: Barbosa, Gisele, et al.
Publicado: (2022)